National HealthCare Corporation (NHC) Analyse boursière

Présentation de l'entreprise

National HealthCare Corporation operates within the healthcare sector, specifically functioning as a provider of services to skilled nursing facilities, assisted and independent living facilities, homecare agencies, hospice agencies, and health hospitals. The company organizes its operations through two distinct segments focused on inpatient services and homecare and hospice services, reflecting a diversified approach to patient care delivery. In terms of scale, the enterprise holds a market capitalization of $2.53 billion and generates annual revenue of $1.52 billion, supporting a workforce of 15,278 employees. These valuation and revenue figures indicate that the company occupies a significant position within the medical care facilities industry, possessing sufficient financial resources to sustain operations across a wide geographic footprint while managing a substantial asset base.

Santé financière

The company reported total revenue of $1.52 billion over the trailing twelve months, accompanied by a net income of $120.02 million and an EBITDA of $173.27 million. The substantial gap between the $1.52 billion in revenue and the $120.02 million in net income highlights a significant cost structure, where operating expenses and taxes absorb approximately $1.4 billion of the top-line revenue before reaching the bottom line. Free cash flow stands at $108.38 million, which demonstrates the company's ability to generate cash beyond capital expenditure requirements, providing financial flexibility for debt servicing, potential acquisitions, or organic expansion initiatives. The company maintains a robust liquidity position with cash holdings of $255.80 million, which notably exceeds its total debt load of $87.07 million. This disparity, coupled with a debt-to-equity ratio of 8.10, suggests a balance sheet that is heavily leveraged relative to equity but currently supported by strong cash reserves. Short-term liquidity is further evidenced by a current ratio of 1.82, indicating that the firm possesses $1.82 in current assets for every $1 of current liabilities, a level generally considered healthy for covering immediate obligations. Regarding return metrics, the company achieves a Return on Equity of 11.9% and a Return on Assets of 5.3%, revealing that management is effectively utilizing shareholder equity to generate profits, though the asset return suggests capital intensity in its service delivery model.

Évaluation de la valorisation

Valuation metrics for National HealthCare Corporation show a Trailing Twelve Months P/E ratio of 21.22 and a Forward P/E of 378.49. The dramatic divergence between these two figures, where the forward multiple is significantly higher, implies that the market expects a substantial increase in future earnings per share to justify the current price, or alternatively, that future earnings are projected to be highly volatile or currently depressed relative to historical averages. The price-to-book ratio stands at 2.37, indicating that the market values the company at a significant premium over its book value, suggesting confidence in the quality of its assets and intangible brand value within the healthcare sector. Alternative valuation measures include a price-to-sales ratio of 1.67 and an EV/EBITDA of 13.66, which provide context on how the market prices the company's revenue generation and operational profitability relative to peers. The stock has traded within a 52-week range between a low of $89.14 and a high of $174.54, with the current trading price situated at a specific point within this historical volatility band. The beta of 0.59 indicates that the stock's price volatility is approximately 41% lower than the broader market, suggesting it behaves as a defensive asset that is less sensitive to general market fluctuations.

Growth & Income

Revenue growth for the trailing twelve months is recorded at 4.6%, while earnings growth has surged to 306.3% year-over-year. This disparity, where earnings growth vastly outpaces revenue growth, implies significant leverage in the cost structure or a one-time adjustment in expenses that has disproportionately boosted the bottom line without a corresponding increase in sales volume. As a dividend payer, the company offers a yield of 1.6% with a payout ratio of 33.0%. This payout ratio is highly sustainable given the robust earnings growth and the fact that the company retains approximately two-thirds of its earnings, allowing for continued reinvestment into operations while still returning capital to shareholders. The combination of moderate revenue expansion and exceptional earnings expansion, supported by a conservative cash balance and a sustainable dividend, creates a unique income profile that balances current yield with the potential for future capital appreciation.